Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
financials
Biotech
Century, Candel, MacroGenics call time on trials to save cash
Century Therapeutics, Candel and MacroGenics all used third-quarter earnings releases to disclose how they’re fine-tuning their clinical pipelines.
James Waldron
Nov 13, 2025 10:15am
Grail sees Q3 sales jump, eyes Q1 for FDA Galleri PMA submission
Nov 13, 2025 9:05am
GE HealthCare Q3 earnings outpace expectations
Nov 5, 2025 4:00am
Illumina sales flat in Q3 amid China headwinds
Oct 31, 2025 8:55am
LabCorp's diagnostics shine in Q3, but revenue forecast dims
Oct 28, 2025 10:15am
Acquisitive Boston Scientific sees growth rate ease in Q3
Oct 22, 2025 10:05am
